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target tissue is detected by autoradiography or non-invasively by 
  fluorodeoxyglucose   (FDG)-PET scanning, techniques that have 
found wide application in functional mapping of the brain and 
for detection of tumors throughout the body. Useful as they are, 
deoxyglucose uptake, deoxyglucose autoradiography, and FDG-
PET scanning have their limitations. Firstly, they use glucose ana-
logs that are not handled by hexokinase in the same way as glucose, 
and that can be toxic, even at low doses (Kurtoglu et al., 2007). 
Secondly, the accumulation of glucose analogs is not just deter-
mined by metabolism but also depends on how efficiently they are 
imported and exported by glucose transporters. Thirdly, isotopic 
techniques offer low spatiotemporal resolution, which precludes 
resolving the contribution of individual cells or detecting rapid 
phenomena; and finally, they are relatively insensitive and require 
radioactive isotope manipulation, which makes them inadequate 
for the purposes of high-throughput analysis. An alternative, non-
isotopic approach to the metabolic rate is the measurement of the 
rate of oxygen consumption, which thanks to recent technical devel-
opments is being done with improved temporal resolution but still 
requires cell populations (Gerencser et al., 2009).
Fluorescence allows estimation of metabolite concentration 
with high sensitivity and spatiotemporal resolution. In addition to 
NAD(P)H autofluorescence (Brennan et al., 2006; Shuttleworth, 
2010), the increasing availability of genetically encoded fluores-
cent biosensors has made it possible to measure the free cytosolic 
concentration of several metabolites as well as their accumula-
tion and elimination rates (Deuschle et al., 2005; Berg et al., 
INTRODUCTION
The metabolic rate defines the speed at which the body burns fuel. 
Inside tissues, each cell is characterized by a specific metabolic rate, 
ranging from low for quiescent cells like fibroblasts to very high for 
active muscle cells and neurons. Mammalian cells can metabolize 
fatty acids, ketone bodies, and aminoacids, but for most cells the 
main fuel is glucose and a tight correlation is observed between met-
abolic rate and glycolytic rate. Brain tissue represents an extreme 
case, where glucose provides 95% of the total energy supply. The 
metabolic rate of an individual cell can vary through time: for 
instance, adipocytes increase their rate of glucose uptake by up to 
ten-fold in response to insulin, whereas neurons may raise their 
energy demand by larger factors in response to electrical stimula-
tion. The metabolic rate is also affected by aging and disease. For 
example, cancer cells show higher metabolic rates than their normal 
counterparts, a phenomenon involved in tumor progression and 
instrumental for the purposes of diagnosis, staging and prognosis 
of this disease (Vander Heiden et al., 2009; Yeluri et al., 2009).
There are no available methods to measure the metabolic rate 
in single cells. Cell populations and tissues are usually studied 
by following the uptake of radioactive metabolites. In a typical 
in vitro experiment, a million cells in a culture dish are exposed 
for 20 min to radiolabeled deoxyglucose, which is phosphorylated 
in the cytosol by hexokinase, and the radioactivity trapped inside 
cells  is  assumed  to  be  proportional  to  the  glycolytic  rate.  For 
in vivo experiments, the tracer is given intravenously, and after a 
period of 20 or more minutes, radioactivity accumulated in the 
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2009). Whereas metabolite concentrations are interesting per se, 
the   presence of homeostatic mechanisms in living cells makes 
steady-state concentrations of little value for the purposes of flux 
prediction. In the present article, these issues have been solved 
by interrupting the steady-state, while measuring the concen-
tration of glucose with a genetically encoded FRET nanosensor. 
Two complementary variants of the method are described that 
measure metabolic flux in several cell types with high sensitivity 
and temporal resolution.
MATERIALS AND METHODS
MATERIALS
Gramicidin, nigericin, standard chemicals and tissue culture reagents 
were from Sigma (St. Louis, MO, USA). Calcein AM was obtained 
from Molecular Probes (Eugene, OR, USA). Constructs coding 
for the sensors FLIPglu170n, FLIPglu600μ∆11, FLII12Pglu600μ∆6 
have been described previously (Fehr et al., 2003; Deuschle et al., 
2005; Takanaga et al., 2008). Plasmids are available through www.
addgene.org.  Adenoviral  vectors  Ad  FLIPglu600μ∆11  and  Ad 
FLII12Pglu600μ∆6 were custom made by Vector Biolabs.
ANIMALS, CELL CULTURE, AND TISSUE SLICES
Animals used were mixed F1 male mice (C57BL/6J × CBA/J), kept 
in an animal room under SPF conditions at a room temperature of 
20 ± 2°C, in a 12/12 h light/dark cycle with free access to food and 
water. All experiments were approved by the Centro de Estudios 
Científicos Animal Care and Use Committee. Mixed cortical cul-
tures of neuronal and glial cells were prepared from 1- to 3-day-
old neonatal mice as described in (Loaiza et al., 2003), except 
that N1-N2/MEM was replaced by B27-supplemented Neurobasal 
medium (Gibco). In culture, astrocytes and neurons can be dis-
tinguished easily under phase contrast microscopy because astro-
cytes are large (>20 μm), poorly birefringent, do not have long 
prolongations and form a monolayer that lies flat against the 
substrate, whereas neurons are smaller, highly birefringent, show 
long prolongations and lie on top of the astrocytic monolayer. 
These morphological criteria have been validated in our labora-
tory with cell-specific antibodies (Loaiza et al., 2003). Cultures 
were maintained at 37°C in a humidified atmosphere of 5% CO2. 
At days 5–7, cultures in 35 mm dishes were transfected with 5 μg 
plasmid DNA using Lipofectamine 2000 (Gibco) or alternatively, 
exposed to 5 × 106 PFU of adenoviral vector. Adenoviral vectors 
showed a very high selectivity for astrocytes over neurons, with 
a ratio >100. Cell lines were obtained from the American Tissue 
Culture Collection (ATCC). 3T3-L1 fibroblasts were maintained 
in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10% fetal calf serum, 2.5 μg/ml amphotericin B and 100 U/ml 
penicillin/streptomycin and differentiated into adipocytes using 
5 μg/ml insulin as described (Nie and Wong, 2008). C2C12 myob-
lasts and Hela cells were maintained in DMEM supplemented with 
10% fetal bovine serum, 2.5 μg/ml amphotericin B and 100 U/ml 
penicillin/streptomycin. 3T3-L1 fibroblast and adipocytes grow-
ing in 10 cm dishes were electroporated with 15 μg plasmid DNA 
using the BioRad Gene Pulser XCell. HeLa cells in 35 mm dishes 
were transfected with 5 μg plasmid DNA using Lipofectamine 
2000. Hippocampal slices (200 μm thick) were prepared with 
a Vibratome 1000 Plus (Warner Instruments) from 15 day-old 
mice according to standard procedures (Ridoux et al., 1995). 
Briefly, brains were immersed in ice-cold artificial   cerebrospinal 
fluid of the following composition (in mM): 125 NaCl, 2.5 KCl, 
1.25 NaH2PO4, 2.5 MgCl2, 0.5 CaCl2, 25 glucose, 26 NaHCO3, 
that had been previously bubbled with 5% CO2/95% O2 for 1 h 
to reach pH 7.4. Hippocampi were dissected from coronal slices 
and incubated for 1–2 h in cold dissection medium. Slices were 
then transferred to 35 mm Petri dishes and cultured at 37°C in a 
humidified atmosphere of 5% CO2 for 5–6 days in 50 % (MEM 
containing 6.5 g/l glucose, 23 mM HEPES, and 26 mM NaHCO3), 
25% fetal bovine serum, 25% Hank’s solution containing 6.5 g/l 
glucose, 0.3% glutamine, 1 mM sodium pyruvate, non-essential 
amino acids, N2 supplement (Invitrogen), 100 U/ml penicillin and 
100 μg/ml streptomycin. Slices were infected for 24 h with 50 × 106 
PFU of adenoviral vectors at day 2 of culture. For immunohis-
tochemistry, slices were fixed overnight in 4% paraformaldehyde 
in phosphate buffered saline (PBS). After extensive washing with 
PBS, slices were incubated overnight at 4°C with rabbit 1:500 anti-
cow GFAP antisera (Dako). After further washing with PBS, the 
tissue was incubated overnight at 4°C with 1:500 Alexa Fluor 568 
goat anti-rabbit IgG (Molecular Probes). Slices were mounted on 
DakoCytomation medium (Dako) and imaged with a Pascal 5 
Zeisss confocal microscope at 488 excitation/505-550 emission 
(for YFP/Citrine) and 543 excitation/>580 nm emission (for Alexa 
Fluor 568).
GLUCOSE AND vOLUME MEASUREMENTS
All experiments were carried out at room temperature (22–25oC), 
which allows easier control, particularly when switching between 
different perfusates. However, the methods are equally effective 
at other temperatures and glycolytic rates have been success-
fully measured at 37°C in our laboratory using a temperature-
controlled microplate reader (data not shown). Cultured cells 
were  imaged  in  HEPES-buffered  saline  containing  (in  mM): 
136 NaCl, 3 KCl, 1.25 CaCl2, 1.25 MgSO4, 1–2 glucose, 2 sodium 
lactate, 10 HEPES, pH 7.4 or in 95% O2/5% CO2-gassed buffer 
of the following composition (in mM): 112 NaCl, 3 KCl, 1.25 
CaCl2, 1.25 MgCl2, 1–2 glucose, 2 sodium lactate, 10 HEPES, 24 
NaHCO3, pH 7.4. Brain slices were superfused with a 95% O2/5% 
CO2-gassed buffer containing (in mM): 126 NaCl, 3 KCl, 1.25 
NaH2PO4, 1.25 CaCl2, 1.25 MgCl2, 2–3 glucose, 1 sodium lac-
tate, 26 NaHCO3, pH 7.4. Lactate is an important fuel for brain 
cells and is likely to exert control of glycolysis in the brain and 
also in tumors. It was added at concentrations similar to those 
found in brain interstitium (Barros and Deitmer, 2010). When 
using higher K+ concentrations, NaCl was adjusted to maintain 
isotonicity. Cultures and slices were imaged with an Olympus 
IX70 inverted microscope equipped with a 40× oil-immersion 
objective, a Cairn monochromator with Optosplit (Faversham, 
UK), and a Hamamatsu Orca camera (Hamamatsu City, Japan) 
controlled by Kinetics software.
Most experiments were carried out with FLII12Pglu600μ∆6 and 
some were repeated with FLIPglu600μ∆11, giving similar results. 
FLII12Pglu600μ∆6 is a fusion protein comprising a FRET donor 
(CFP) and a FRET acceptor (Citrine) linked by a bacterial pro-Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  3
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were evaluated with the respective versions of the Student’s t-test. 
P values <0.05 were considered significant and are indicated with 
an asterisk.
RESULTS
THEORy
The concentration of glucose can be measured in single cells using 
FRET nanosensors (Fehr et al., 2003; Deuschle et al., 2005; Takanaga 
et al., 2008; Takanaga and Frommer, 2010). Accumulation and elimi-
nation rates can be determined by altering the supply of glucose in 
the medium. However, both accumulation and elimination rates are 
a factor of at least three flux components: uptake, phosphorylation 
by hexokinase and efflux. The intracellular concentration of glucose 
in the steady state is also determined by these three components but 
it does not inform on their relative weight (Figure 1A). For example, 
a low glucose concentration may be observed in cells that have few 
transporters or in cells with high glycolytic rates. In order to obtain 
an estimate of flux through hexokinase, i.e., the rate of glycolysis at 
its entry point, we devised two strategies that disrupt the steady-state. 
In the first variant, termed ETM (Equilibrium-Transport-Method), 
extracellular glucose levels are dropped in a single step to a concen-
tration lower than intracellular glucose but different from 0. The 
numerical simulation in Figure 1B, predicts that such perturbation 
leads to a rapid decrease toward a new steady-state. Critically, there 
is an instant in the course of the relaxation when glucose concentra-
tions inside and outside are identical. Because equilibrative transport 
mediated by GLUTs dominates glucose uptake into most mammalian 
cells, net flux through the transporter in the absence of a gradient is 0. 
Thus, with the contribution of transport eliminated, the rate at which 
glucose concentration falls at equilibrium will correspond to the rate 
of hexokinase. Given that the Km of the enzyme is 40–50 μM (Wilson, 
2003), the rate measured at 300 μM will represent a close estimate 
of the Vmax. The second variant, termed ITM (Inhibition-Transport-
Method) isolates the rate of metabolism by eliminating the contribu-
tion of transport by pharmacological block of the GLUT transporters. 
Figure 1C shows a model of how inhibition of transport causes a 
quasi-linear fall in intracellular glucose, a linearity that results from 
the high affinity of hexokinase for glucose, which remains nearly 
saturated as glucose falls from the millimolar range into the hundred 
micromolar range. Thus the rate of glucose decrease after blocking 
transport is also a good estimate of the Vmax of hexokinase.
vALIDATION Of THE METHODS
The theoretical predictions were first tested in cultured astrocytes, 
cells in which glucose uptake is mediated predominantly by GLUT1, 
a well-characterized member of the SLC2 family of facilitative hexose 
and polyol transporters (reviewed in Barros and Deitmer, 2010). 
Cytosolic glucose levels were measured in real-time with a genetically 
encoded FRET glucose nanosensor (Fehr et al., 2003; Deuschle et al., 
2005; Takanaga et al., 2008). In the presence of 2 mM extracellular 
glucose, cultured astrocytes maintained a steady-state intracellular 
glucose concentration averaging 0.63 ± 0.30 mM (n = 100 cells in 
twenty two experiments). Intracellular glucose concentration varied 
greatly from cell to cell, ranging from 0.2 to 1.9 mM, meaning that in 
some cells flux is mostly controlled by transporters and in others by 
the glycolytic machinery. ETM was applied by lowering extracellular 
tein that upon binding glucose or galactose changes its confor-
mation and the distance between the FRET pair, thus changing 
FRET efficiency (Fehr et al., 2003; Deuschle et al., 2005; Takanaga 
et al., 2008). FRET results are usually given as ratio between emis-
sion intensities of Citrine and CFP upon CFP excitation, but we 
chose not to use CFP emission because of its weak intensity due 
to the high FRET efficiency of this sensor. Instead, Citrine was 
excited directly at 512 nm, which provided a sugar-insensitive 
denominator for the FRET ratio. Thus, each experimental point 
involved a measurement of Citrine emission (520–550 nm) excited 
by FRET at 430 nm for 300–800 ms, followed immediately by a 
measurement of Citrine emission (520–550 nm) excited directly 
at 512 nm for 33–100 ms. Data were encoded in 14 bits and the 
camera was shown to behave linearly in the range of 200–10,000 
gray units. Due to variations in sensor expression, exposure times 
were adjusted for each experiment so that in a typical ROI average 
intensity was between 1,000 and 4,000.
Another advantage of this modified protocol is that it does not 
require an image splitter, so that with the right filters it can be 
installed in a standard calcium imaging setup. The ratio between 
Citrine emission excited by FRET and excited directly was con-
verted into glucose concentration by exposing pH-clamped cells 
to increasing glucose concentrations in the presence of the glyco-
lytic blocker iodoacetic acid (500 μM). Cells were pH-clamped by 
permeabilizing the plasma membrane to protons using 100 μM 
nigericin and 10 μM gramicidin. With glycolysis blocked, extra-
cellular and intracellular glucose equilibrate, allowing calibration 
of the ratio. For astrocytes, 3T3-L1 fibroblasts, C2C12 myoblasts 
and HeLa cells, KD values (mM) were 0.42, 0.30, 0.49, and 0.28, 
with respective ∆Rmax values (%) of 27, 24, 25, and 27 (n = 3 or 
more experiments for each cell type with standard errors lower 
than 20% of the parameter value). For neurons and adipocytes, 
whose low glucose permeability made calibration impractical, 
we used the parameters obtained in astrocytes and fibroblasts, 
respectively. Relative cell volume was measured using a Pascal 
5 Zeisss confocal microscope (optical section <2 μm; 488 nm 
excitation/505–550 nm emission) in cells ester-loaded with cal-
cein at 0.5 μM for 30 min (Barros, 1999). Exposure to anisos-
motic solutions showed that over 90% of the fluorescence was 
volume-sensitive.
MODELING GLUCOSE HOMEOSTASIS
Glucose transport across the plasma membrane was simulated 
using the simple carrier model of GLUT1 as described in (Barros 
et al., 2007), with a carrier concentration of 0.2 μM. Hexokinase was 
simulated as a Michaelis–Menten process, with a Km of 50 μM and 
a Vmax of 5 μM/s. The system of differential equations was solved by 
numerical simulation using Berkeley Madonna. Transporter block 
by cytochalasin B considered the inhibitor to be interacting with 
the inward-facing conformation of the carrier with a KD of 1 μM 
(Carruthers, 1990).
STATISTICAL ANALySIS
Regression analyses were carried out with the computer program 
SigmaPlot (Jandel). Data are presented as mean ± SEM throughout 
the paper. Differences in mean values of paired or unpaired samples Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  4
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most cell types, GLUT1, GLUT3, and GLUT4, with a Ki of about 1 μM 
or lower (Carruthers, 1990). As predicted, exposure of astrocytes 
to the inhibitor resulted in a linear decrease in the concentration 
of glucose in the cytosol (Figure 3A). When exposed continuously 
to cytochalasin B, cytosolic glucose reached levels indistinguish-
able from 0, demonstrating complete inhibition of transport. The 
average rate of glycolysis in cultured astrocytes was 2.0 ± 0.3 μM/s 
(n = 120 cells in thirty experiments) and showed high heterogeneity, 
even inside a microscopic field (data not shown). Several control 
experiments were designed to check the validity of ITM. In addi-
tion to inhibiting glucose transport, cytochalasin B affects the actin 
cytoskeleton, a potential source of interference that can be control-
led for with cytochalasin D, a structural analog that specifically tar-
gets the cytoskeleton but not the glucose transporters (Carruthers, 
1990). The experiment illustrated in Figure 3A (inset) supports the 
specificity of cytochalasin B by showing that cytochalasin D did not 
affect the   concentration of glucose. Galactose, which is also a ligand 
glucose to 0.3 mM, a change that under our superfusion conditions 
took less than 5 s. As predicted by the simulation in Figure 1B, a 
step reduction of extracellular glucose caused a progressive decline 
in cytosolic glucose concentration (Figures 2A,B). The rate of gly-
colysis was estimated by fitting a monoexponential function to the 
time-course of decay and computing the instantaneous slope at 
0.3 mM (interrupted line in Figure 2B). The assay was repeated 
multiple times using the same cells. As illustrated in Figure 2C, the 
response was quantitatively reproducible, i.e., the rate was unaf-
fected by previous treatment, suggesting that the assay itself does 
not perturb glycolysis, e.g., by altering expression or activity levels of 
participating proteins. This insensitivity of metabolism to a moder-
ate decrease in intracellular glucose is consistent with constancy of 
metabolic flux while hexokinase remains saturated.
The second approach, ITM, makes use of pharmacological inhi-
bition of glucose transport. A widely used inhibitor of the glucose 
transporter is cytochalasin B, which blocks the major   isoforms of 
FiguRE 1 | Two strategies to measure the rate of glycolysis. Glucose dynamics 
were modeled in cell endowed with the equilibrative glucose transporter GLUT1 
and hexokinase (HK), using numerical simulation as described in Materials and 
Methods. (A). At 2 mM extracellular glucose, the intracellular concentration of 
glucose is kept constant at 1 mM by the dynamic balance between glucose influx 
and its intracellular phosphorylation by hexokinase. (B) For ETM, the steady-state 
is disrupted by a step decrease in extracellular glucose, in this case to 0.3 mM, 
which causes a slow decrease in intracellular glucose. When intracellular and 
extracellular glucose are equal (arrow), there is no net transfer of sugar across the 
plasma membrane, and therefore the rate of glucose decrease in that instant is 
identical to the rate of glycolysis, represented by the interrupted line. (C) For ITM, 
the steady-state is disrupted by blockage of the glucose transporter, leading to a 
progressive decline in intracellular glucose at the rate of glycolysis (interrupted 
line), providing an extended window of measurement.Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  5
Bittner et al.  FRET measurement of glycolysis
over seconds. For instance, neuronal activity is accompanied by sub-
second shifts in mitochondrial redox potential (Brennan et al., 2006; 
Shuttleworth, 2010), followed within seconds by a rise in interstitial 
lactate (Hu and Wilson, 1997a), which is thought to play key roles 
in fast neurovascular and neurometabolic coupling (Pellerin et al., 
2007; Gordon et al., 2008; Magistretti, 2009). The observation in 
cultured astrocytes that glutamate stimulates 2-deoxyglucose uptake 
and lactate release led to the hypothesis that neuronal activity is 
preferentially fueled by astrocytic lactate (Pellerin and Magistretti, 
1994). However, given the limited resolution of available techniques 
to measure metabolic flux the identity of the cell type responsi-
ble for the lactate surge (i.e., neurons versus astrocytes) and the 
identity of the local signals that link electrical activity to metabolic 
activation remain controversial (Dienel and Cruz, 2004; Pellerin 
et al., 2007; Mangia et al., 2009; Barros and Deitmer, 2010). Taking 
advantage of ability of ITM to follow glycolytic activation in real-
time, we explored the early effects of glutamate and K+, molecules 
that are released by excitatory neurons during neurotransmission. 
The data, summarized in Figure 4, show that these neuronal signals 
trigger a robust and rapid increase in the rate of glycolysis in astro-
cytes. Remarkably, the activation was stronger than the activation 
achieved by mitochondrial poisoning (compare with Figure 3E). A 
control experiment showed that the fast fall in glucose concentra-
tion observed in response to glutamate/K+ can not be explained by 
sugar dilution during cell swelling (Figure 5). In cultured astro-
cytes, a major fraction of the glucose that enters glycolysis leaves 
the cell as lactate (Barros and Deitmer, 2010). By showing for that 
astrocytic glycolysis can be activated by neuronal signals in the 
for the nanosensors (Fehr et al., 2003), is not metabolized by brain 
cells (Barros et al., 2007), allowing precise control of its cytosolic 
concentration by extracellular manipulation. To control for a pos-
sible direct effect of cytochalasin B on the sensor, the inhibitor 
was applied to   galactose-equilibrated cells expressing FLIPglu170n. 
This high-affinity version of the sensor is always saturated, thus 
providing a constant readout, whose change may be unambigu-
ously ascribed to an artifact. However, as illustrated in Figure 3B, 
cytochalasin B did not change the ratio of FLIPglu170n emission 
intensity, showing that there is no direct effect of the inhibitor on 
the sensor. As with ETM, ITM was also reproducible, giving simi-
lar rates in multiple assays (Figure 3C). Phloretin, a structurally 
unrelated inhibitor of the glucose transporter, gave a glycolytic 
rate of 1.7 ± 0.3 μM/s that was not significantly different from the 
glycolytic rate obtained with cytochalasin B (1.8 ± 0.3 μM/s; n = 20 
cells in three paired experiments). Figures 3D, E show that measure-
ment of hexokinase flux using ITM presents the expected sensitivity 
to interruption of glycolysis with the GAPDH blocker iodoacetic 
acid (IAA) and to stimulation of glycolysis with the mitochondrial 
inhibitor rotenone. Finally, the methods were compared using the 
protocol illustrated in Figure 3F, and as expected, their outputs 
were well correlated.
TEMpORAL RESOLUTION: ACUTE ACTIvATION Of ASTROCyTIC 
GLyCOLySIS by NEURONAL SIGNALS
Typical acquisition times in deoxyglucose uptake, deoxyglucose 
autoradiography and FDG-PET scanning are longer than 10 min, 
but the metabolic changes that characterize the brain tissue develop 
FiguRE 2 | Experimental demonstration of ETM in astrocytes. (A) A single 
astrocyte expressing the FRET glucose nanosensor FLII12Pglu600μ∆6 was switched 
from 2 mM to 0.3 mM glucose. Data are background-corrected average 
fluorescence intensities in the specified region of interest (square) for Citrine 
emission as excited by FRET (430 nm; Top panel), as excited directly (512 nm; middle 
panel) and the ratio between both emissions (lower panel). Bar represents 20 μm. 
(B) Ratios from Figure 2A, were converted to intracellular glucose concentrations 
using the calibration parameters (Materials and Methods). A monoexponential 
function was fitted to the data during the decrease in glucose concentration 
(continuous line), yielding a glycolytic rate of 1.2 μM/s as computed from the slope at 
0.3 mM glucose (interrupted line). (C) Reproducibility of the assay. The glycolytic rate 
was measured twice in the same cell (top trace). The bottom graph summarizes 
data from 20 cells in five independent experiments in which the protocol was 
applied twice. Each cell is represented by a different symbol.Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  6
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FiguRE 3 | Experimental demonstration of iTM in astrocytes. (A) Exposure 
of a nanosensor-expressing astrocyte to 20 μM cytochalasin B resulted in a linear 
decrease in glucose concentration at a rate of 5 μM/s (interrupted line). The inset 
shows that the same concentration of cytochalasin D had no effect on glucose 
concentration. (B) Lack of effect of cytochalasin B on the ultra-high affinity form 
of the sensor (FLIPglu170n) saturated with 4 mM galactose (n = 8 cells in three 
experiments). (C) Reproducibility of the assay. The glycolytic rate was measured 
twice in the same cell (top trace). The graph summarizes sixteen independent 
experiments in which the protocol was applied two to four times in the same cell, 
giving similar rates. Each cell is represented by a different symbol. (D) Rates were 
measured before (white symbols) and during (black symbols) inhibition of 
glycolysis with 500 μM IAA (n = 15 cells in three experiments; *p < 0.05 with 
respect to control rate). (E) The inhibitor of oxidative phosphorylation rotenone 
(2 μM) was applied during glycolytic rate determination (n = 12 cells in three 
experiments; *p < 0.05 with respect to control rate). (F) Glycolytic rates were 
measured with ETM and ITM in succession as illustrated in the top panel. The 
bottom panel summarizes the data for 28 cells in seven experiments, with a solid 
line indicating equal rates for both methods.
range of seconds, these results suggest that astrocytes contribute 
to the lactate surge observed during neuronal activation. Previous 
confocal microscopy measurements with fluorescent glucose ana-
logs 2-NBDG and 6-NBDG have shown that exposure of cultured 
astrocytes to glutamate leads to a strong stimulation of the glucose 
transporter GLUT1 that also develops within seconds (Loaiza et al., 
2003; Porras et al., 2008). In view of the present data, the stimulation 
of the GLUT1 may be seen as a mechanism that prevents astrocytic 
glucose shortage in times of high neuronal activity.
SpATIAL RESOLUTION: NEURONS vERSUS ASTROCyTES
Thanks to new imaging approaches based on fluorescent proteins 
and nanosensors, the structure and function of the brain tissue are 
being characterized in increasing detail (Livet et al., 2007; Dulla et al., 
2008). However, the energy usage of the brain   tissue has not been 
mapped with the same level of resolution. Each   millimeter-sized 
voxel of an autoradiograph or PET scan, standard methods to 
  measure metabolic rate, is populated by scores of different neuronal 
and glial types, and a specific rate of fuel consumption of individual Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  7
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cells is currently not accessible. Moreover, there is an open debate 
on whether glucose is preferentially metabolized by neurons or 
astrocytes (Dienel and Cruz, 2004; Bonvento et al., 2005; Nehlig 
and Coles, 2007; Pellerin et al., 2007; Barros and Deitmer, 2010). 
The experiments illustrated in Figures 6A, B show for the first time 
the simultaneous measurement of the glycolytic rate in a neuron 
and a neighboring astrocyte in vitro. We observed great variability 
of the basal metabolic rate in both cell types but on average the 
faster cell was the astrocye. Because rates are presumably affected 
by local factors, results in cultured cells do not predict the situa-
tion in the brain tissue, but given that the FRET nanosensor may 
be targeted to specific cell types in vivo by means of viral vectors or 
transgenesis, this kind of measurement may eventually be carried 
out in the brain tissue in vivo. As an initial step in that direction, 
the sensor was expressed in hippocampal slices using an adenoviral 
vector. Figure 6C shows colocalization between the sensor and the 
glial protein GFAP, consistent with the known preferential targeting 
of glial cells by adenoviruses. Similar to that observed in cultured 
cells, Figures 6D, E show that the glycolytic rate in astrocytes in 
slices was heterogeneous, with an average of 2.8 ± 0.4 μM/s (n = 68 
cells in twenty five  slices, ranging from 0.02 to 12 μM/s). Using 
this adenoviral vector in slices we did not observe any cells with 
obvious neuronal morphology.
MEASUREMENT Of METAbOLIC RATE IN ADIpOCyTES, MUSCLE CELLS, 
AND TUMOR CELLS
The metabolic rate of adipocytes, muscle cells, and epithelial cells is 
a parameter of importance for the pathogenesis of diabetes mellitus 
and cancer. In order to test the applicability of ITM in these cell 
types, the FRET nanosensor was expressed in several cell lines using 
liposome transfection. The results included in Figure 7, show high 
metabolic rates in undifferentiated cells and tumor cells (3T3-L1 
fibroblasts, C2C12 myoblasts, and HeLa cells), whereas differentia-
tion of fibroblasts into adipocytes led to a marked decrease in their 
rate of metabolism. These results confirm previous data obtained 
FiguRE 4 | Temporal resolution: fast and strong activation of astrocytic 
glycolysis by neuronal signals. (A) Application of ITM to a single astrocyte (with 
20 μM cytochalasin B) revealed a basal glycolytic rate of 0.7 μM/s (interrupted line 
over white symbols), which jumped to 2.3 μM/s after addition of 50 μM 
glutamate and 12 mM K+ (interrupted line over black symbols). (B) Summary of 
four similar experiments (n = 17 cells; *p < 0.05 with respect to control rate).
with radioactive techniques but reliance of the present methods on 
fluorescence makes them more amenable for the purposes of high-
throughput analysis using microtiter plates. An additional contribu-
tion of fluorescence-based methodologies is the observation that 
cultured cell lines are highly heterogeneous in terms of metabolic 
rate. We did not observe an obvious correlation between Citrine flu-
orescence intensity and glycolytic rate (Figure 8), indicating that the 
heterogeneity is not due to a possible effect of sensor expression.
DISCUSSION
Brain tissue is composed by many different cell types, each one 
characterized by unique energy requirements and most likely by 
a specific way to ensure proper energy delivery. However, most 
of this rich microscopic detail remains hidden because current 
techniques to measure metabolic flux have limited spatiotemporal 
resolution (Barros, 2010). The present article has introduced two 
new strategies for the measurement of the metabolic rate, whose 
common rationale is the isolation of glucose phosphorylation by 
eliminating the   contribution of the glucose transporters. These 
methods offer a temporal resolution of seconds and a spatial 
resolution of micrometers, comparing favorably with standard 
methods based on 2-deoxyglucose, which offer a temporal reso-
lution of minutes and a spatial resolution of millimeters. Some 
elegant variations of the 2-deoxyglucose method have achieved 
cellular resolution but for long term measurements (Vega et al., 
2003; Nehlig et al., 2004; Nehlig and Coles, 2007). In addition to 
high resolution an important advantage of the present methods 
is the use of glucose itself, as opposed to glucose analogs, whose 
handling by hexokinase and posterior fates are often uncertain. 
One of these analogs, 2-NBDG, the fluorescent version of deoxy-
glucose, can be resolved at cell level, but its uptake is not directly 
informative about metabolic rate because, is three orders of mag-
nitude slower than glucose uptake and sensitive to the properties 
of the glucose transporter (Loaiza et al., 2003; Yamada et al., 2007; 
Barros et al., 2009).Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  8
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for data acquisition, usually less than 1 s, providing an extended 
window of measurement that can be used to explore acute modu-
lation of metabolism in real time. The main advantage of ETM is 
that is less invasive as it does not require addition of a pharmaco-
logical inhibitor. Cytochalasin B affects the actin cytoskeleton and 
may interfere with glycolytic enzymes or with proteins modulating 
glycolysis in unanticipated ways. Although this was not found to 
be the case in astrocytes, control experiments with cytochalasin D 
(Figure 3) are advised when dealing with a new cell type. Also, as 
ETM does not require an inhibitor, it can be applied to hepatocytes 
and pancreatic beta-cells, which are rich in GLUT2 and therefore 
relatively insensitive to cytochalasin B and phloretin. An ideal ver-
sion of ITM would use a yet-to-be-developed potent but reversible, 
specific and non-permeant inhibitor of GLUTs. ETM assumes that 
the transport of glucose across the membrane is equilibrative, which 
is known to be the case for most mammalian cell types, both normal 
and malignant, but not so for some epithelial cells in intestine and 
kidney, which express the Na+-coupled glucose transporter SGLT. 
In those cells ETM can not be used, but ITM may be still applicable 
with the addition of phloridzin or another SGLT blocker. In cells 
expressing glucose-6-phosphatase, which are capable of synthesiz-
ing glucose, both methods can be applied, but instead of giving the 
metabolic rate they will report the net difference between glucose 
usage and glucose production. In summary, we advise that new cell 
types or conditions should first be approached with both ITM and 
ETM. Estimation of similar rates with both methods will indicate 
that cytochalasin B does not affect glycolysis per se and along cyto-
chalasin D control assays, will validate the more robust ITM in that 
  particular system. Correct   application of the methods requires either 
rapid delivery of the inhibitor or a step-like change in extracellular 
glucose concentration, which are easily attainable in monolayers of 
cultured cells and thin tissue slices. Cytochalasin B is highly hydro-
phobic and penetrates tissues quite rapidly but depending on the 
distances involved, its diffusion into thick tissues and intact organs 
in vivo may have to be corrected for. A similar caveat applies to 
ETM regarding quick control of extracellular glucose concentra-
tion. The glucose sensor is a protein and its expression demands 
energy and other cell resources that may in principle influence cell 
metabolism. Although finding a lack of correlation between sensor 
expression and glycolytic rate helps to discard expression level as a 
major confounding factor (e.g., Figure 8), expression should best 
be kept at the minimum compatible with the sensitivity of available 
recording devices. Another general concern when using molecular 
sensors is the possible effect of the sensor on the concentration of 
the molecule that is being measured, a factor that is critical for Ca2+ 
and pH measurements, in which sensor and analyte may be present 
at similar nanomolar concentrations and the sensor becomes a sig-
nificant buffer. This is not the case for glucose, which is present at 
high micromolar levels or more and is not expected to be influenced 
by typical protein sensor concentrations.
Two original observations were made with the new methods 
demonstrating their improved temporal and spatial resolution. 
Firstly, it was possible for the first time to observe that astrocytic 
glycolysis can be activated within seconds by neuronal signals. 
Previous measurements of deoxyglucose uptake over 20 min had 
given conflicting results (Dienel and Cruz, 2004; Bonvento et al., 
2005; Nehlig and Coles, 2007; Pellerin et al., 2007), but the present 
Both ETM and ITM offer cellular resolution and are reversible, 
presenting different strengths and weaknesses that make them com-
plementary. ITM is more robust, requiring only a   straightforward 
linear fit to the data, as opposed to ETM, which involves fitting an 
exponential equation and calculating an instantaneous slope, opera-
tions that demand high quality data. A second advantage of ITM 
over ETM is that the former can be applied regardless of how slow 
is the metabolic rate. For instance, a very slow rate of glycolysis may 
still be measured over 20 s but measuring a very slow rate with ETM 
will demand impractically long determinations, e.g., 20 min or more, 
and therefore be affected by focus drifts, temperature variation, cell 
movement, sample evaporation, etc. Thirdly, the temporal resolu-
tion of ITM is much better and only limited by the time required 
FiguRE 5 | Effect of glutamate/K+ on astrocytic cell volume. 
(A) Fluorescence was measured in a calcein-loaded cell during addition of 
50 μM glutamate/12 mM K+, followed by a solution in which NaCl had been 
reduced to make the solution 30% hypotonic (hypo). Relative calcein 
concentration was calculated from calcein fluorescence using the response to 
hypotonicity as a calibration factor. (B) The initial time course of the response 
to glutamate/K+ shown in A (calcein) is plotted together with an example of 
relative decrease in glucose concentration elicited by K+ (glucose, same data 
as shown in Figure 4A). (C) Initial rates of decrease are given for a series of 
experiments with glutamate/K+ for glucose (n = 25 cells in five experiments) 
and calcein (n = 20 cells in three experiments), *p < 0.05.Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  9
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high resolution lactate and/or O2 measurements may help to clarify 
the important issue of how much glucose goes to lactate and how 
much goes to CO2.
In addition, the improved spatial resolution of the methods 
allowed monitoring, for the first time, the glycolytic rate of a neu-
ron lying on an astrocytic bed. Given the inherent limitations of 
isotopic measurements, previous work had measured these cells 
in isolation, but this is not ideal because both cell types require 
each other for proper differentiation and functional specializa-
tion. The present results in co-culture showed high cell-to-cell 
variability and on average astrocytes were found to metabolize 
glucose faster than neurons. Astrocytes could also be studied in 
brain slices, suggesting that in the near future it will be possible 
to compare the metabolic rates of both cells types in the tissue, 
in slices and in vivo. The cell-to-cell variability was not related to 
level of sensor expression, suggesting that it is a reflection of their 
biology and not due to stress resulting from protein overproduc-
tion. There are subtypes of astrocytes in the brain that can be 
method, with its temporal resolution of seconds, was able to show 
that astrocytic glycolysis is highly sensitive to mediators that are 
released at the excitatory synapse. The strength and speed of the 
glycolytic activation observed provides a mechanistic explanation 
for the fall in glucose concentration and the surge in lactate con-
centration that can be detected in the brain tissue 5–20 s after the 
onset of neuronal activation (Silver and Erecinska, 1994; Hu and 
Wilson, 1997a,b; Mangia et al., 2003; Caesar et al., 2008), sup-
porting a central role for astrocytes in metabolic coupling and 
blood flow regulation in the brain (Gordon et al., 2008; Magistretti, 
2009). Cultured astrocytes are known to release abundant lac-
tate under basal conditions so it seems likely that the stimulation 
of glycolysis by glutamate/K+ leads to augmented lactate release. 
However, it should be borne in mind that these were measure-
ments with abundant oxygen and that an increase in glycolytic 
rate does not necessarily imply an increase in lactate production, 
for a fast stimulation in mitochondrial pyruvate oxidation is also 
a theoretical   possibility. Future technical   developments allowing 
FiguRE 6 | Spatial resolution: simultaneous measurement of glycolytic 
rate in neighboring astrocytes and neurons. Two examples of simultaneous 
measurement of glycolytic rate in a neuron (n) and an adjacent astrocyte (a) in a 
dispersed culture are shown. Whereas for example (A), the astrocyte is faster 
than the neuron, in (B) the opposite is true. The other astrocyte pictured in b also 
presented a low metabolic rate. Bars represent 25 μm. Image contrast was 
enhanced to make neuronal processes more visible. (C) Hippocampal slices 
were infected as described in Materials and Methods. Confocal images show 
colocalization of the glucose nanosensor (top) and the astrocytic marker GFAP 
(bottom). Bar represents 10 μm. (D) Slices were superfused with 2 mM glucose 
and ITM was applied, giving a rate of 6.3 μM/s. (E) Distribution histogram of the 
rates obtained for 68 cells in 25 slices.Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  10
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distinguished electrophysiologically and by preferential expres-
sion of Na+-glutamate cotransporters or metabotropic glutamate 
receptors. Other sources of variation that are valid for astrocytes 
and also for the other cells types are cell cycle staging, degree of 
contact inhibition, and cell viability. All these possibilities are now 
open to further investigation.
In order to demonstrate the use of these methods in non-neural 
cell types, we chose fibroblasts, adipocytes, and myoblasts, cells 
that are widely used for basic research and drug-screening. The 
hypoglycemic effect of insulin is largely caused by an increase in 
the metabolic rate of adipocytes and muscle cells, a process that 
becomes defective in diabetes; we envisage that the current meth-
ods may be useful for basic and applied research related to this 
disease. High metabolic rates were observed in HeLa, a human 
epithelial cell line widely used in cancer research. The enhanced 
glycolytic rate observed in tumor cells, i.e., the Warburg effect, 
is exploited for the purposes of diagnosis and staging by means 
of FDG-PET scanning, and has recently been proposed to play a 
pathogenic role in cancer progression (Vander Heiden et al., 2009). 
Simultaneous respirometry and pH measurement with fluorescent 
sensors has been implemented successfully in multi-well format to 
assess metabolism in cell populations with resolution of minutes 
(Gerencser et al., 2009). The techniques to measure glycolytic rate 
that were described in this article are readily adaptable to multi-well 
format and may be used alongside respirometry for the purposes 
of high-throughput investigation of cellular metabolism in cancer 
and other diseases.
FiguRE 8 | Lack of clear correlation between level of sensor expression 
and glycolytic rate. The glycolytic rate was measured in cultured astrocytes 
using ITM and the result is plotted against the fluorescence intensity of the 
sensor as excited at 512 nm, divided by camera exposure time in milliseconds. 
Excitation intensity and camera gain were identical in all experiments, so this 
normalized intensity serves as a parameter of sensor abundance. Each kind of 
symbol represents cells from a single experiment (n = 80 cells from seven 
experiments).
FiguRE 7 | Heterogeneity of glycolytic rates in various cell types. Confocal 
imaging of the glucose sensor expressed in astrocytes (A), neurons (B), 3T3-L1 
fibroblasts (C), 3T3-L1 adipocytes (D), C2C12 myoblasts (E), and HeLa cells (F), 
displaying its expected cytosolic distribution, with exclusion of nuclei and organelles. 
Graphs summarize glycolytic rates obtained with ITM, with averages represented by 
a horizontal line (n > 14 cells in at least four experiments in each cell type).Frontiers in Neuroenergetics  www.frontiersin.org  September 2010  | Volume 2  | Article 26  |  11
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